NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹189 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹147 Cr |
| Mar2022 | ₹180 Cr |
| Mar2021 | ₹170 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹189 Cr | 55.02 | |
| Mar2024 | ₹122 Cr | -16.73 | |
| Mar2023 | ₹147 Cr | -18.42 | |
| Mar2022 | ₹180 Cr | 5.90 | |
| Mar2021 | ₹170 Cr | - | |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,087.3 Cr | -3.5% | -6.8% | 8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.5% |
-6.8% |
8.8% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses